Vaccines May Offer Double Protection Against Dementia, Study Suggests

Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections

AS01-adjuvanted shingles (herpes zoster) vaccination is associated with a lower risk of dementia, but the underlying mechanisms are unclear. In propensity-score matched cohort studies with 436,788 individuals, both the AS01-adjuvanted shingles and respiratory syncytial virus (RSV) vaccines, individually or combined, were associated with reduced 18-month risk of dementia. No difference was observed between the two AS01-adjuvanted vaccines, sugges…

RSV Vaccine Tied to Lower Dementia Risk

(MedPage Today) -- Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the recombinant shingles vaccine (Shingrix) -- were tied to a lower dementia risk, an analysis of over 400...

Could a vaccine adjuvant be protective against dementia?

Scientists behind a study suggesting GSK's RSV vaccine may be protective against dementia have said the adjuvant used in it may be responsible.

Vaccine for RSV shown to reduce the risk of dementia

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how vaccines produce this effect.

Vaccines may offer double protection against dementia_ study suggests

Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their added “adjuvant” chemicals as well as by suppressing viruses,

Vaccines may offer double protection against dementia, study suggests

Oxford research shows adjuvant chemicals included in vaccinations may enhance their antiviral effect